Ann: First Commercial Sale of APAS Independence, page-59

I have been bearish in previous posts regarding LBT and still believe that there will be an upside to this company.
The first sale was expected and is a positive, but it has not been enough to change investor sentiment at this point of time. Time lines haven’t been met and all promised milestones have yet to be delivered. I understand the frustration of some posters.
Humans are pretty basic, stimulus and response.
If you were fortunate a few months ago to purchase a million shares at 10 cents and under your sentiment will be better than a longer term investor who has a million shares at .50 cents. Some investors may have taken short term profits, overs may need cash. Some investors may be experiencing investor fatigue with the LBT story and decided to get out.
I believe that this has come into play with this company.
Investor sentiment will improve further when further positive announcements are made to the market. They don’t all need to bee to be price sensitive, they do need to be factual and reflect the work that is going on.
The announcement that a further Australian laboratory was trialling the APAS machine was a positive one. In my mind this is a potential sale. Unfortunately it was included in the Wound Vu announcement. I would have liked to see this as an announcement in its own right. I can cite other announcements which may have mixed messages affecting investor sentiment.
Further short term announcements that may improve sentiment…
Submission of 510k supplement, opening up the US market
Completion of the MRSA module.
CE approval
Announcement of the European distributor.
Potential sales to a German laboratory
Be under no illusion, this is a speculative stock. If milestones are achieved in a timely manner and further sales are made there will be an upside by years end. If not then the result will be self evident. That's how speculation works....
(Disclosure held LBT since 2015, average price .15.)